ALRPD.PA Rapid Nutrition PLC EURONEXT -18.97% intraday 20 Jan 2026: volume spike

ALRPD.PA Rapid Nutrition PLC EURONEXT -18.97% intraday 20 Jan 2026: volume spike

The ALRPD.PA stock slid -18.97% intraday on EURONEXT to EUR 0.0047 on 20 Jan 2026, driven by a volume surge to 19,745,133 shares. This rapid move makes Rapid Nutrition PLC one of today’s most active European small-caps. Traders should note the gap from the 50-day average of EUR 0.003 and the 200-day average of EUR 0.005 when sizing positions.

ALRPD.PA stock intraday price action

ALRPD.PA opened at EUR 0.0055 and hit a session low of EUR 0.0045 and high of EUR 0.0058. The intraday decline of -18.97% followed heavy turnover, with current volume 1.02x average. One clear claim: active trading today signals shorter-term liquidity and higher volatility for Rapid Nutrition PLC on EURONEXT.

Financials and valuation measures for ALRPD.PA stock

Rapid Nutrition PLC reports EPS -0.02 and reported a negative PE at -0.27. Market cap stands near EUR 2,612,137 with 474,933,967 shares outstanding. Key ratios show price-to-sales at 6.41 and price-to-book near 50.56, indicating premium valuation versus tiny revenues. One clear claim: fundamentals reflect a small revenue base and stretched valuation relative to company size.

Technical indicators and volume signals

Momentum indicators show RSI near 64.22 and ADX 27.10, suggesting a trending move. The stock’s 50-day average is EUR 0.003 and 200-day average is EUR 0.005. On balance volume (OBV) is elevated at 123,784,800, confirming buying and selling pressure. One clear claim: technicals point to strong intraday activity, not a calm consolidation.

Sector position and market context

Rapid Nutrition PLC operates in Healthcare, the Drug Manufacturers – Specialty & Generic industry. The broader Healthcare sector shows muted gains this week. One clear claim: ALRPD.PA stock moves are idiosyncratic and not driven by sector-wide momentum in Europe.

Risks, catalysts and trading considerations

Risks include low free cash flow, extended receivables cycles, and narrow liquidity for large orders. Catalysts include the next earnings date on 04 Apr 2025 and any clinical or distribution updates. One clear claim: short-term traders should size exposure to intraday volume spikes and thin order books.

Analyst signals plus Meyka AI grade and outlook

Meyka AI rates ALRPD.PA with a score out of 100: 58.06 (Grade C+, Suggestion: HOLD). This grade factors in S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. Independent firm ratings show a company-level score of C- dated 19 Jan 2026, recommending Strong Sell. One clear claim: Meyka AI grade is neutral while third-party signals are negative, underlining mixed views.

Final Thoughts

Key takeaways: ALRPD.PA stock is trading at EUR 0.0047 on EURONEXT after an intraday fall of -18.97% and a surge to 19,745,133 shares. Fundamentals show EPS -0.02, negative PE, and high price-to-book, which signal valuation stress given small revenue per share. Technicals indicate active momentum but also higher short-term risk. Meyka AI’s forecast model projects EUR 0.010 as a base scenario. Versus the current price of EUR 0.0047, that implies an upside of 112.77%. We stress that forecasts are model-based projections and not guarantees. Traders should weigh tight liquidity, company news flow, and the upcoming earnings update on 04 Apr 2025 when planning entries. For live quotes and deeper metrics see our ALRPD.PA page and recent market coverage

FAQs

What is the current price of ALRPD.PA stock and today’s move?

ALRPD.PA stock trades at EUR 0.0047 on EURONEXT today, down 18.97% intraday with volume 19,745,133 shares, marking it one of the most active small-caps on the session.

What valuation concerns should investors note for ALRPD.PA stock?

Valuation red flags include a negative PE (-0.27), high price-to-book (50.56), and price-to-sales around 6.41. These indicate a stretched valuation against a small revenue base and thin liquidity.

What is Meyka AI’s outlook and forecast for ALRPD.PA stock?

Meyka AI’s forecast model projects EUR 0.010 for ALRPD.PA. That implies 112.77% upside from EUR 0.0047, but forecasts are model-based projections and not guarantees.

When is Rapid Nutrition PLC due to report earnings?

Rapid Nutrition PLC lists an earnings announcement for 04 Apr 2025. That report is a key catalyst likely to influence ALRPD.PA stock price and intraday liquidity.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *